Professor Andrew Nisbet was appointed Head of Medical Physics at the Royal Surrey County Hospital NHS Foundation Trust and Professor of Medical Physics at Surrey University in 2006. He graduated in Physics at the University of Edinburgh before completing an MSc in Medical Physics at the University of Aberdeen and subsequently a PhD from the same University. Prior to taking up appointment in Guildford he was Head of Radiotherapy Physics within the Medical Physics Department at the Oxford Radcliffe Hospitals NHS Trust.
The Department of Medical Physics includes the Regional Radiation Protection Service, Radiotherapy Physics, Radiopharmacy & Nuclear Medicine Physics, Scientific Computing, Technical Services and the Department also hosts the National Coordinating Centre for the Physics of Mammography on behalf of the NHS Breast Screening Programme.
Professor Nisbet has been a member of the Technology Subgroup of the National Radiotherapy Advisory Group, which produced an influential report on planning future radiotherapy services in England. He is an expert in the implementation of advanced radiotherapy techniques and the assessment of risk from such treatments. He has worked closely with the National Physical Laboratory in providing national recommendations on the measurement of dose for radiotherapy. He has been a consultant for the International Atomic Energy Agency producing guidelines for the on-site auditing of radiotherapy departments and has sat on the Panel of Scientific Experts for a European Union funded grant with the objectives of performing an EU-wide study on the implementation of Medical Exposure Directive requirements aimed at the reduction of the probability and the magnitude of accidents in radiotherapy and developing guidelines on a risk analysis of accidental and unintended exposures in external beam radiotherapy and, therefore, improving patient safety.
As Principal or co-Investigator he has held grants in excess of £6m. As Head of the Medical Physics Department and Co-Investigator he has been involved in two CRUK / EPSRC /MRC/ NIHR Cancer Imaging Programme Grants investigating the optimisation of digital technology for mammographic screening. He has helped develop the dosimetric methodology for determining cardiac dose from breast radiotherapy employed in a major international epidemiological study funded by the European Union, for which he was Partner and lead medical physicist, and which has recently published its results in the New England Journal of Medicine. He has been a co-investigator on a Department of Health funded grant examining the adaption of medical imaging systems for body monitoring in the event of a radiological incident. He has also been PI for two NIHR invention for innovation grants, in collaboration with the National Physical Laboratory, developing a novel superconducting quantum interference device (SQUID) based microbolometer for the measurement of radiobiological effect from particle therapy beams.
He has supervised 12 PhD, 3 MD and numerous MSc postgraduate students and has published over 80 papers in peer reviewed journals. He is currently primary or co-supervisor to a further 8 PhD students and 1 MD fellow.